Forward Science Technologies Introduces F.A.C.T.™ Oral Health Protocol
The proactive protocol aims to provide clinicians with a systematic approach to assess oral abnormalities with a combination of the latest technologies
By: Forward Science Technologies LLC
In an effort to give clinicians the tools they need, Forwards Science Technologies LLC continues to move science forward and introduces the F.A.C.T.™ Oral Heath Protocol, a proactive approach for a complete oral health assessment. F.A.C.T., an acronym for Fluorescence Assessment and Cytology Test, combines the proven technology of fluorescence and the power of liquid cytology so clinicians can get the answers they need.
The protocol begins with the standard of care white-light visual and palpation. Next, the OralID is utilized for the enhanced fluorescence assessment. If a lesion is discovered and further information is required, CytID, a next generation liquid based cytology test, is then used to determine the severity of the lesion.
The objective of the clinician during an oral health assessment is to find potential problems and abnormalities, in efforts to address the conditions in the earliest possible stage. As with other oral conditions, this proactive approach is critical in diagnosing oral cancer in its earliest stages. Until recently, we have only used our eyes and palpation for a complete oral assessment. Now with advancing technologies, we have the ability to “highlight”
“The F.A.C.T. Oral health protocol puts dentistry in the medical arena, with a proactive approach for a complete oral health assessment utilizing the latest medical technology.”
Used by over 10,000 clinicians and conducting over 20 million screenings, fluorescence technology is quickly becoming a preferred technology to enhance the oral health assessment. Fluorescence technology assists in discovering abnormal lesions at the earliest stages. Recognizing more than just cancer, fluorescence technology allows for the discovery of many oral abnormalities from a palatal burn or lichen planus to squamous cell carcinoma. CytID is the advanced liquid based cytology test to answer the question: When you need to know more™. While it is not a replacement for a biopsy, CytID provides the quantitative data needed to make a more informed plan of action.
The F.A.C.T. Oral Heath Protocol provides us with a system to discover more information allowing the clinician to evaluate their patient's health with the latest tools available to provide the best oral health examination.
“We believe this new protocol is a standard of care game changer in the years to come. It is a 21st Century technology to battle 21st Century oral health issues,” said Luis Rivera VP of Sales for Forward Science Technologies.
To learn more about the F.A.C.T. Oral Health Protocol, visit OralID.com or Cyt-ID.com.
ABOUT Forward Science Technologies LLC
Forward Science Technologies LLC is a privately held medical device company based in Houston, Texas. With the launch of CytID, Forward Science Technologies becomes the first company in the United States to provide an oral health protocol. In addition to being the only FDA Cleared oral cancer screening device with no per patient costs, OralID caries a sector leading 2-year warranty. As an intermediary test before a biopsy, CytID provides clinicians with a quick and painless test for “when you need to know more”.
Page Updated Last on: Apr 21, 2014